Table 1.
Baseline demographics and clinical characteristics of patients a
| Demographics and characteristics | Data |
|---|---|
| Demographics and anthropomorphic measures | |
| Age (years) |
51.0 (±14.2) |
| Females (%) |
82.4% (28) |
| Race, Caucasians (%) |
85.3% (29) |
| Weight (kg) |
77.3 (±18.1) |
| BMI (kg/m2) |
28.28 (±6.04) |
| Disease-related and laboratory indices | |
| DAS28-CRP (units) |
4.58 (±1.10) |
| Tender joints (n) |
9.68 (±6.96) |
| Swollen joints (n) |
8.38 (±4.66) |
| VAS (mm) |
43.0 (±28.5) |
| CRP (mg/dl) |
12.69 (±24.57) |
| ESR (mm/h) |
22.8 (±21.3) |
| HOMA (units) |
3.11 (±2.68) |
| Current medication use | |
| Methotrexate (%) |
70.6% (24) |
| Leflunomide (%) |
14.7% (5) |
| Sulfasalazine (%) |
2.9% (1) |
| Hydroxycholorquine (%) |
17.6% (6) |
| Biologic (%) |
52.9% (18) |
| Corticosteroid (%) | 52.9% (18) |
aData are presented as mean (±SD) for continuous data and percentage (number) for categorical variables. BMI, body mass index; CRP, high-sensitivity C-reactive protein; DAS28-CRP, Disease Activity Score in 28 joints high-sensitivity C-reactive protein; ESR, erythrocyte sedimentation rate; HOMA, homeostatic model assessment of insulin resistance; VAS, Visual Analogue Scale for Global Health.